Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6189382 | Brachytherapy | 2014 | 10 Pages |
Abstract
Although D90 values of <130Â Gy were predictive of an increased risk of recurrence in the non-ADT subset, neither D90 nor V100, when used as continuous variables, was predictive of DFS when applied to the entire cohort or in the subset analysis. This observation informs us that dose metrics are not equivalent to oncologic end points and must be calibrated against DFS for each physician and each institution offering LDR-PB.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
W. James Morris, Ingrid Spadinger, Mira Keyes, Jeremy Hamm, Michael McKenzie, Tom Pickles,